Skip to content
DataLookout
Menu

OCCSNCT07928024

Impact of Oral vs. Transdermal Oestrogen on Cortisol & CBG Before SST

StatusCompleted
PhaseNot specified
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Changes in cortisol binding globulin (CBG) concentration and serum cortisol levels
Timeframe: 6 weeks

Secondary (1)

Salivary cortisol and cortisone levels

Arms and interventions

Oral oestrogen group

Women taking oestrogen pills - They will stop taking them for up to six weeks, as required for standard care.

Transdermal oestrogen group

Women using oestrogen gel or patches - They will stop taking them for up to six weeks, as required for standard care.

Control group

Women not taking any oestrogen - This control group will help compare results.

Sites

1 site in 1 country

  • Norfolk and Norwich University Hospitals NHS Foundation TrustNorwich, Norfolk, United Kingdom